Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

SOLIGENIX, INC. (SNGX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

SOLIGENIX, INC. (SNGX), most recent 12 months reported: net loss $10.24M, free cash flow -$10.27M. From SEC filings. Others in Pharmaceutical Preparations: Skye Bioscience, Inc. · SELLAS Life Sciences Group, Inc. · Summit Therapeutics Inc. · Semnur Pharmaceuticals, Inc. · Spruce Biosciences, Inc. · Savara Inc · SYNLOGIC, INC. · Spyre Therapeutics, Inc.

Stock screener

Watchlist